- Home
- AZI vs IGMS Comparison
AZI vs IGMS Comparison
Compare AZI & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZI
- IGMS
- Stock Information
- Founded
- AZI 2010
- IGMS 1993
- Country
- AZI China
- IGMS United States
- Employees
- AZI N/A
- IGMS N/A
- Industry
- AZI
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- AZI
- IGMS Health Care
- Exchange
- AZI Nasdaq
- IGMS Nasdaq
- Market Cap
- AZI 84.9M
- IGMS 82.1M
- IPO Year
- AZI 2024
- IGMS 2019
- Fundamental
- Price
- AZI $1.00
- IGMS $1.23
- Analyst Decision
- AZI
- IGMS Hold
- Analyst Count
- AZI 0
- IGMS 8
- Target Price
- AZI N/A
- IGMS $6.14
- AVG Volume (30 Days)
- AZI 186.1K
- IGMS 190.3K
- Earning Date
- AZI 01-27-2025
- IGMS 05-07-2025
- Dividend Yield
- AZI N/A
- IGMS N/A
- EPS Growth
- AZI N/A
- IGMS N/A
- EPS
- AZI N/A
- IGMS N/A
- Revenue
- AZI $124,737,000.00
- IGMS $2,679,000.00
- Revenue This Year
- AZI N/A
- IGMS $106.64
- Revenue Next Year
- AZI N/A
- IGMS $68.35
- P/E Ratio
- AZI N/A
- IGMS N/A
- Revenue Growth
- AZI 9.86
- IGMS 25.77
- 52 Week Low
- AZI $0.45
- IGMS $1.11
- 52 Week High
- AZI $4.05
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- AZI N/A
- IGMS 40.11
- Support Level
- AZI N/A
- IGMS $1.11
- Resistance Level
- AZI N/A
- IGMS $1.31
- Average True Range (ATR)
- AZI 0.00
- IGMS 0.08
- MACD
- AZI 0.00
- IGMS 0.04
- Stochastic Oscillator
- AZI 0.00
- IGMS 61.54
About AZI Autozi Internet Technology (Global) Ltd. Class A Ordinary Shares
Autozi Internet Technology (Global) Ltd is one of China's leading and fast-growing lifecycle automotive service providers. It provides high-quality, affordable, and professional one-stop automotive products and services through online and offline channels nationwide. Leveraging its online supply chain cloud platform, SaaS platforms, and the network of MBS stores, It has established an ecosystem of lifecycle automotive services by connecting automotive manufacturers, auto parts manufacturers, and insurance companies with MBS stores and various automotive owners. Its business segments include new car sales, auto parts and auto accessories sales, and automotive insurance-related services. The majority of revenue is from the new car sales segment, and auto parts & auto accessories sales.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.